WEBVTT 00:00:00.000 --> 00:00:02.160 If you've been anywhere near a hospital or, you 00:00:02.160 --> 00:00:04.000 know, even just watch the news this fall, you've 00:00:04.000 --> 00:00:06.360 likely heard about a supply chain crunch that 00:00:06.360 --> 00:00:09.960 is almost unbelievable in its simplicity and 00:00:09.960 --> 00:00:13.699 its severity. We're talking about the 2024 IV 00:00:13.699 --> 00:00:17.420 fluid shortage, and it has laid bare a level 00:00:17.420 --> 00:00:20.320 of vulnerability in our essential medical infrastructure 00:00:20.320 --> 00:00:23.980 that. frankly, is terrifyingly high stakes. It's 00:00:23.980 --> 00:00:26.039 the perfect illustration of systemic risk, and 00:00:26.039 --> 00:00:27.679 that's precisely what we're diving into today. 00:00:27.940 --> 00:00:31.399 The direct cause was, well, massive weather hurricane 00:00:31.399 --> 00:00:35.340 Helene back in September 2024. Right. That storm 00:00:35.340 --> 00:00:38.299 caused catastrophic flooding, and it hit one 00:00:38.299 --> 00:00:42.020 single manufacturing facility, just one, in Marion, 00:00:42.100 --> 00:00:44.240 North Carolina. And that single facility belongs 00:00:44.240 --> 00:00:46.820 to the subject of our deep dive, Factor International. 00:00:47.240 --> 00:00:49.280 But here's the shocking nugget, the one that 00:00:49.280 --> 00:00:51.619 should alarm every single person listening, especially 00:00:51.619 --> 00:00:54.700 you, who might rely on this system someday. That 00:00:54.700 --> 00:00:57.159 one facility, the Marion plant, produces approximately 00:00:57.159 --> 00:01:03.759 60%. 60%. 60 % of the intravenous or IV fluids 00:01:03.759 --> 00:01:06.400 used across the entire United States. I mean, 00:01:06.400 --> 00:01:09.700 help me understand. Does any other critical infrastructure, 00:01:10.000 --> 00:01:12.959 electricity, water treatment, have a vulnerability 00:01:12.959 --> 00:01:16.579 ratio that high. How unusual is that? It is exceptionally 00:01:16.579 --> 00:01:19.760 unusual. And, you know, it's fundamentally problematic 00:01:19.760 --> 00:01:22.200 for a product that is literally the baseline 00:01:22.200 --> 00:01:25.200 of modern medical care. Yeah. 5E fluids aren't 00:01:25.200 --> 00:01:28.159 specialty drugs. They are the water, the electrolytes, 00:01:28.180 --> 00:01:30.680 the delivery mechanism for, well, for almost 00:01:30.680 --> 00:01:32.760 everything else. Yeah. So the immediate fallout 00:01:32.760 --> 00:01:35.060 was exactly what you'd expect. A sudden halt 00:01:35.060 --> 00:01:37.260 of critical infrastructure. Nationwide shortages. 00:01:37.620 --> 00:01:39.579 Exactly. They hit emergency rooms and operating 00:01:39.579 --> 00:01:42.269 theaters. Almost immediately. Hospitals were 00:01:42.269 --> 00:01:44.269 forced to ration supplies. They had to implement 00:01:44.269 --> 00:01:46.950 conservation strategies. And they were worrying 00:01:46.950 --> 00:01:48.989 about the impending flu season hitting an already 00:01:48.989 --> 00:01:51.849 depleted stockpile. We are talking about doctors 00:01:51.849 --> 00:01:54.689 changing protocols for, like, simple dehydration 00:01:54.689 --> 00:01:57.409 treatment. Postponing elective surgeries. And 00:01:57.409 --> 00:02:00.510 having to substitute expensive specialty products 00:02:00.510 --> 00:02:04.510 for basic, cheap saline solutions. Even now, 00:02:04.569 --> 00:02:07.670 as of November 2024, I heard the facility resumed 00:02:07.670 --> 00:02:10.319 some production. But the industry... is still 00:02:10.319 --> 00:02:11.900 playing catch up, right? Oh, absolutely. This 00:02:11.900 --> 00:02:14.360 wasn't a momentary blip. It was a sustained stress 00:02:14.360 --> 00:02:16.500 test of the entire health care supply chain. 00:02:16.639 --> 00:02:19.360 So that immediately raises a huge question that 00:02:19.360 --> 00:02:22.759 goes way beyond weather. Who is this company, 00:02:22.860 --> 00:02:25.780 Baxter International, that holds such a critical, 00:02:25.960 --> 00:02:28.960 non -redundant portion of our national health 00:02:28.960 --> 00:02:31.580 care in its hands? I mean, if they're this essential, 00:02:31.840 --> 00:02:34.240 why is the system so dependent on them? And why 00:02:34.240 --> 00:02:36.599 does one natural disaster shut down the country's 00:02:36.599 --> 00:02:39.909 access to saline? Baxter is, by all measures, 00:02:40.009 --> 00:02:43.210 a titan. They are a Fortune 500 company, an S 00:02:43.210 --> 00:02:45.610 &P 500 component headquartered up in Deerfield, 00:02:45.689 --> 00:02:48.370 Illinois. They specialize in products for chronic 00:02:48.370 --> 00:02:50.870 and acute medical conditions, everything from 00:02:50.870 --> 00:02:53.949 IV solutions and dialysis equipment to surgical 00:02:53.949 --> 00:02:56.409 technologies. But the sheer market share, the 00:02:56.409 --> 00:02:58.650 absolute necessity of their products demands 00:02:58.650 --> 00:03:01.610 we look far beyond their glossy corporate overview. 00:03:01.770 --> 00:03:04.699 We have to ask. What is the full history of a 00:03:04.699 --> 00:03:07.500 company that is somehow simultaneously this essential 00:03:07.500 --> 00:03:10.259 and this consistently controversial? Okay, so 00:03:10.259 --> 00:03:13.159 let's unpack this. Our mission for this deep 00:03:13.159 --> 00:03:16.259 dive is to explore Baxter's history. We're going 00:03:16.259 --> 00:03:18.180 to look at the groundbreaking innovation that 00:03:18.180 --> 00:03:20.939 made them indispensable and then contrast that 00:03:20.939 --> 00:03:24.219 with a consistent Decades long pattern of product 00:03:24.219 --> 00:03:29.439 defects, contamination scandals and some serious 00:03:29.439 --> 00:03:31.939 legal compromises. Right. We need to figure out 00:03:31.939 --> 00:03:34.659 why a critical provider of lifesaving supplies 00:03:34.659 --> 00:03:37.699 is so frequently embroiled in major controversies. 00:03:37.740 --> 00:03:40.080 And what that history tells us about the fragility 00:03:40.080 --> 00:03:42.460 of the global medical supply chain you and I 00:03:42.460 --> 00:03:46.060 and everyone listening rely on. So let's start 00:03:46.060 --> 00:03:48.430 at the beginning. Baxter International wasn't 00:03:48.430 --> 00:03:51.729 always this sprawling, multinational entity. 00:03:51.830 --> 00:03:54.030 It started with a single doctor trying to solve 00:03:54.030 --> 00:03:56.530 a very specific problem in the early 20th century. 00:03:56.710 --> 00:03:58.990 That's right. The company was founded in 1931 00:03:58.990 --> 00:04:01.409 by Dr. Donald Baxter. He was a medical doctor 00:04:01.409 --> 00:04:04.069 based in Los Angeles. Okay. And his initial goal 00:04:04.069 --> 00:04:07.259 was pretty straightforward. to manufacture and 00:04:07.259 --> 00:04:09.819 distribute intravenous therapy solutions. At 00:04:09.819 --> 00:04:12.020 the time, IV solutions were often made in -house 00:04:12.020 --> 00:04:14.039 by hospitals. Right, which sounds incredibly 00:04:14.039 --> 00:04:17.439 risky. It was. It led to inconsistencies, major 00:04:17.439 --> 00:04:20.800 quality control issues, and serious risks of 00:04:20.800 --> 00:04:24.839 infection. So Baxter sought to standardize and 00:04:24.839 --> 00:04:26.959 industrialize that whole process. They pretty 00:04:26.959 --> 00:04:29.040 quickly realized they needed better infrastructure 00:04:29.040 --> 00:04:33.269 and, I guess, access to a more central hub. That 00:04:33.269 --> 00:04:34.850 led to the opening of a dedicated manufacturing 00:04:34.850 --> 00:04:37.649 plant in Glenview, Illinois, just two years later 00:04:37.649 --> 00:04:40.449 in 1933. And then the real pivotal moment happened 00:04:40.449 --> 00:04:42.750 when Dr. Baxter's interest was bought out in 00:04:42.750 --> 00:04:46.290 1935 by a man named Ralph Falk. And Falk was 00:04:46.290 --> 00:04:49.670 the one with the vision for R &D. Exactly. Falk 00:04:49.670 --> 00:04:51.709 is a person who recognized that the future wasn't 00:04:51.709 --> 00:04:54.490 just in selling IV solutions, but in improving 00:04:54.490 --> 00:04:57.170 medical technology. He formalized the company's 00:04:57.170 --> 00:04:59.250 focus on research and development, and that really 00:04:59.250 --> 00:05:01.310 set the stage for their truly significant innovations. 00:05:01.689 --> 00:05:03.889 So they weren't just content to deliver basic 00:05:03.889 --> 00:05:06.310 fluids. Not at all. They aimed to improve the 00:05:06.310 --> 00:05:09.189 entire handling and delivery process for fluids 00:05:09.189 --> 00:05:11.449 and maybe even more importantly for blood. That 00:05:11.449 --> 00:05:15.009 focus led to some truly seismic, life -saving 00:05:15.009 --> 00:05:17.449 milestones that really cemented their reputation. 00:05:18.889 --> 00:05:21.930 I'm thinking specifically about 1939, when they 00:05:21.930 --> 00:05:24.290 developed a vacuum -type collection container. 00:05:24.569 --> 00:05:26.410 It sounds like a small thing, doesn't it? A bitter 00:05:26.410 --> 00:05:29.410 bottle. It does, but that seemingly small innovation, 00:05:29.750 --> 00:05:32.290 just a better way to collect blood, critically 00:05:32.290 --> 00:05:34.810 extended the shelf life of stored blood from 00:05:34.810 --> 00:05:37.490 mere hours to weeks. Think about the impact of 00:05:37.490 --> 00:05:40.569 that one invention alone. It radically transformed 00:05:40.569 --> 00:05:43.930 the logistics of surgery and wartime medicine. 00:05:44.350 --> 00:05:46.129 Suddenly, you could build up blood banks. You 00:05:46.129 --> 00:05:48.490 could transport blood safely over long distances. 00:05:48.750 --> 00:05:51.149 It established Baxter as an essential force in 00:05:51.149 --> 00:05:53.949 clinical medicine. And then you fast forward 00:05:53.949 --> 00:05:57.050 to 1956, and they introduced the first functioning 00:05:57.050 --> 00:06:00.160 artificial kidney. a device capable of hemodialysis. 00:06:00.420 --> 00:06:02.480 That is just an enormous breakthrough in human 00:06:02.480 --> 00:06:04.879 history. I mean, literally inventing the capacity 00:06:04.879 --> 00:06:07.399 to sustain life for patients suffering from acute 00:06:07.399 --> 00:06:09.819 kidney failure. It's incredible. And by 1971, 00:06:10.120 --> 00:06:12.259 the company's growth was cemented. It officially 00:06:12.259 --> 00:06:14.480 became a member of the prestigious Fortune 500 00:06:14.480 --> 00:06:16.779 list. They had really earned their reputation 00:06:16.779 --> 00:06:19.339 as an innovative health care leader. But as the 00:06:19.339 --> 00:06:21.519 company grew internationally, they started with 00:06:21.519 --> 00:06:24.240 an office in Belgium in 1954, right? That's right. 00:06:24.360 --> 00:06:27.139 And that global reach introduced them to global 00:06:27.139 --> 00:06:29.439 policy. Yeah. And that is where the first serious 00:06:29.439 --> 00:06:32.779 deliberate controversies really began to take 00:06:32.779 --> 00:06:34.920 root in the 70s and 80s. And here we're talking 00:06:34.920 --> 00:06:36.759 about the Arab League boycott, which targeted 00:06:36.759 --> 00:06:39.060 companies doing business with Israel. Exactly. 00:06:39.259 --> 00:06:42.800 In 1971, Baxter built a major manufacturing plant 00:06:42.800 --> 00:06:46.160 in Ashdod, Israel. This was a significant political 00:06:46.160 --> 00:06:48.720 and business decision, and it resulted in the 00:06:48.720 --> 00:06:50.740 company being placed on the Arab League boycott 00:06:50.740 --> 00:06:53.560 list in the early 1980s. So they were effectively 00:06:53.560 --> 00:06:56.620 locked out of a huge market. A substantial market 00:06:56.620 --> 00:06:59.060 the entire Middle East. And that market pressure 00:06:59.060 --> 00:07:02.120 led to what really can only be described as a 00:07:02.120 --> 00:07:04.459 corporate crime aimed at getting market access 00:07:04.459 --> 00:07:08.240 back. This is the 1993 felony conviction. under 00:07:08.240 --> 00:07:11.279 U .S. anti -boycott laws. And this detail is 00:07:11.279 --> 00:07:13.800 what separates a simple political spat from a 00:07:13.800 --> 00:07:16.480 calculated criminal compromise. This is where 00:07:16.480 --> 00:07:18.639 the story gets really complex and, frankly, pretty 00:07:18.639 --> 00:07:21.439 unsavory. It shows a willingness to engage in 00:07:21.439 --> 00:07:23.839 some serious geopolitical maneuvers for profit. 00:07:24.759 --> 00:07:27.620 The allegations stem from actions taken around 00:07:27.620 --> 00:07:30.620 1988. Baxter was accused of selling their profitable 00:07:30.620 --> 00:07:33.819 Ashdod facility to Teva Pharmaceutical Industries. 00:07:34.279 --> 00:07:36.319 Now, on the surface, that looks like a straightforward 00:07:36.319 --> 00:07:38.879 business transaction. But the allegation was 00:07:38.879 --> 00:07:41.339 that the sale was happening at the exact same 00:07:41.339 --> 00:07:44.420 time as negotiations, which they initiated, to 00:07:44.420 --> 00:07:47.540 get off that Arab League blacklist. Yes. And 00:07:47.540 --> 00:07:50.279 the way they negotiated the removal was by agreeing 00:07:50.279 --> 00:07:52.899 to construct a similar manufacturing plant in 00:07:52.899 --> 00:07:55.779 Syria in partnership with a very specific entity, 00:07:56.000 --> 00:07:58.910 the Syrian military. Wow. So they're selling 00:07:58.910 --> 00:08:00.889 an Israeli plan while simultaneously promising 00:08:00.889 --> 00:08:03.389 to build one with the Syrian military. That combination 00:08:03.389 --> 00:08:05.850 divesting a valuable asset in Israel while striking 00:08:05.850 --> 00:08:08.290 a highly sensitive deal with a hostile nation's 00:08:08.290 --> 00:08:10.410 military link entity to get off the boycott list 00:08:10.410 --> 00:08:13.670 was seen by U .S. regulators as a direct criminal 00:08:13.670 --> 00:08:16.569 violation of U .S. anti -boycott law. A law that 00:08:16.569 --> 00:08:18.689 basically prevents American companies from taking 00:08:18.689 --> 00:08:21.149 actions that support an international boycott 00:08:21.149 --> 00:08:24.430 against a U .S. ally. Right. So the company was 00:08:24.430 --> 00:08:26.939 essentially playing both sides for profit. And 00:08:26.939 --> 00:08:30.060 the source material confirms that in 1993, Baster 00:08:30.060 --> 00:08:33.200 pleaded guilty to a felony related to that law. 00:08:33.360 --> 00:08:35.519 This wasn't just a regulatory fine or a small 00:08:35.519 --> 00:08:37.860 slap on the wrist. Not at all. It was a criminal 00:08:37.860 --> 00:08:41.019 conviction tied directly to prioritizing market 00:08:41.019 --> 00:08:44.139 access over compliance and, you know, integrity. 00:08:44.480 --> 00:08:46.639 It paints a picture of a corporation willing 00:08:46.639 --> 00:08:49.299 to make serious compromises when billions of 00:08:49.299 --> 00:08:51.480 dollars were on the line. And that willingness 00:08:51.480 --> 00:08:54.399 to bend rules for massive financial gain, it 00:08:54.399 --> 00:08:56.700 seems to set a kind of cultural tone, doesn't 00:08:56.700 --> 00:08:58.960 it? It certainly didn't stop the company's massive 00:08:58.960 --> 00:09:01.559 organizational shifts and consolidation during 00:09:01.559 --> 00:09:04.600 that same period. In 1985, they engineered a 00:09:04.600 --> 00:09:07.399 massive merger with the American Hospital Supply 00:09:07.399 --> 00:09:10.279 Corporation. That merger was an attempt to create 00:09:10.279 --> 00:09:13.299 what they called a one Baxter approach. The strategy 00:09:13.299 --> 00:09:16.019 was, I mean, revolutionary for its time. Right. 00:09:16.120 --> 00:09:18.080 To become the single source for everything a 00:09:18.080 --> 00:09:20.240 hospital needed, they wanted to provide, what, 00:09:20.360 --> 00:09:23.139 70 % to 80 % of their necessary supplies and 00:09:23.139 --> 00:09:25.860 just streamline the whole procurement process 00:09:25.860 --> 00:09:29.500 under one gargantuan umbrella. And leading this 00:09:29.500 --> 00:09:32.919 transformation was their CEO, Vernon Lox, who 00:09:32.919 --> 00:09:36.559 served from 1980 to 1998. During his almost two 00:09:36.559 --> 00:09:39.389 -decade tenure, Sales more than quadrupled to 00:09:39.389 --> 00:09:42.929 $5 .7 billion. The workforce grew significantly, 00:09:43.090 --> 00:09:46.389 too. It did. From 30 ,000 to 42 ,000, he was 00:09:46.389 --> 00:09:48.389 definitely a major figure in the industry, even 00:09:48.389 --> 00:09:50.269 known for mentoring staff who went on to lead 00:09:50.269 --> 00:09:53.190 other major firms like Caremark and Edwards Life 00:09:53.190 --> 00:09:55.389 Sciences. He really built the modern Baxter. 00:09:55.669 --> 00:09:58.370 But the ending of his tenure, like so many aspects 00:09:58.370 --> 00:10:00.830 of Baxter's history, was messy and controversial. 00:10:01.269 --> 00:10:03.929 Lux was forced to resign by shareholders in 1998. 00:10:04.009 --> 00:10:06.210 Right. It was due to poor performance stemming 00:10:06.210 --> 00:10:08.389 from some unsuccessful merger attempts and just 00:10:08.389 --> 00:10:11.320 overall dips in stock value. And here's where 00:10:11.320 --> 00:10:13.500 the corporate governance detail highlights that 00:10:13.500 --> 00:10:15.980 ethical flexibility again. Even as he was being 00:10:15.980 --> 00:10:18.159 forced out, the board handed him a special stock 00:10:18.159 --> 00:10:20.179 option grant of nine hundred and fifty thousand 00:10:20.179 --> 00:10:22.860 shares for the specific purposes of motivating 00:10:22.860 --> 00:10:25.840 him to implement a smooth transition of his responsibilities. 00:10:26.889 --> 00:10:29.629 That was the official line. Wait, a forced resignation 00:10:29.629 --> 00:10:32.809 rewarded with millions. That paints a very clear 00:10:32.809 --> 00:10:36.049 picture of a board prioritizing management convenience 00:10:36.049 --> 00:10:38.990 over, you know, shareholder accountability. Absolutely. 00:10:39.289 --> 00:10:42.149 At the time, if he immediately exercised and 00:10:42.149 --> 00:10:45.070 sold 400 ,000 shares available to him, he would 00:10:45.070 --> 00:10:47.750 have made more than $4 million, a multimillion 00:10:47.750 --> 00:10:50.070 dollar reward for being told to leave. It sets 00:10:50.070 --> 00:10:52.230 a precedent for how critical leadership transitions 00:10:52.230 --> 00:10:56.500 were managed generously. quietly and internally. 00:10:56.940 --> 00:11:00.460 And this ethical flexibility, as you put it, 00:11:00.519 --> 00:11:02.559 immediately leads us to one of the most famous 00:11:02.559 --> 00:11:05.200 and damaging spinoffs in their history. Caremark. 00:11:05.519 --> 00:11:07.620 The Caremark story is staggering. It shows how 00:11:07.620 --> 00:11:10.220 deeply entrenched corruption can become in a 00:11:10.220 --> 00:11:13.299 specific profit center. Caremark was Baxter's 00:11:13.299 --> 00:11:15.799 home infusion subsidiary. Right. And even before 00:11:15.799 --> 00:11:18.639 the spinoff in 1991, the government accused Caremark 00:11:18.639 --> 00:11:20.799 of systematically paying doctors to steer patients 00:11:20.799 --> 00:11:23.139 to its intravenous drug service. So Baxter spun 00:11:23.139 --> 00:11:26.039 Caremark off in 1992, effectively trying to distance 00:11:26.039 --> 00:11:28.600 the main company from this brewing scandal. But 00:11:28.600 --> 00:11:31.059 that didn't stop the legal fallout. In 1995, 00:11:31.720 --> 00:11:35.279 Caremark was fined a massive $160 million for 00:11:35.279 --> 00:11:38.500 a four -year -long federal mail fraud and kickback 00:11:38.500 --> 00:11:41.139 scheme. And the detail here is crucial for understanding 00:11:41.139 --> 00:11:43.639 just how systemic this corruption was. The home 00:11:43.639 --> 00:11:46.240 infusion business unit was making weekly payments 00:11:46.240 --> 00:11:49.240 to scores of doctors for referrals. The payments 00:11:49.240 --> 00:11:52.179 averaged about $75 per patient, which might not 00:11:52.179 --> 00:11:54.320 sound like a lot on its own. But it added up. 00:11:54.340 --> 00:11:57.080 It added up fast. Some doctors, according to 00:11:57.080 --> 00:11:59.279 government documents, were receiving up to $80 00:11:59.279 --> 00:12:02.299 ,000 annually just for steering patients toward 00:12:02.299 --> 00:12:05.529 Caremark services. So this was a completely systemic, 00:12:05.789 --> 00:12:08.429 volume -based corruption model. It was designed 00:12:08.429 --> 00:12:11.250 to maximize patient flow into their highly profitable 00:12:11.250 --> 00:12:13.850 IV drug service. This tells you a lot about the 00:12:13.850 --> 00:12:15.870 pressure cooker environment of that era of rapid 00:12:15.870 --> 00:12:17.750 health care expansion and profit maximization. 00:12:17.909 --> 00:12:20.289 It shows that when the drive for growth is prioritized 00:12:20.289 --> 00:12:22.690 above all else, ethical lines can become, well, 00:12:22.730 --> 00:12:25.669 nonexistent. Fast forward to the 21st century, 00:12:25.769 --> 00:12:28.730 and we see more massive corporate shifts. In 00:12:28.730 --> 00:12:31.970 2015, Baxter split into two distinct companies. 00:12:32.289 --> 00:12:35.070 Right. You have Baxter International, which kept 00:12:35.070 --> 00:12:37.509 the medical products, the IVs, dialysis equipment, 00:12:37.690 --> 00:12:40.850 and Baxalta, which focused on biopharmaceuticals. 00:12:40.870 --> 00:12:43.029 This was a major strategic separation. They were 00:12:43.029 --> 00:12:45.429 trying to unlock shareholder value by creating 00:12:45.429 --> 00:12:48.049 these two focused entities. But Baxalta didn't 00:12:48.049 --> 00:12:50.850 last long as an independent entity. Shire acquired 00:12:50.850 --> 00:12:55.789 Baxalta in 2016 for the huge sum of $32 billion. 00:12:56.860 --> 00:12:59.419 Which just demonstrates the immense value embedded 00:12:59.419 --> 00:13:01.980 in Baxter's historical R &D and pharmaceutical 00:13:01.980 --> 00:13:04.600 portfolio. Absolutely. And Baxter International, 00:13:04.960 --> 00:13:06.960 the company we're focusing on, has continued 00:13:06.960 --> 00:13:09.360 his strategy of mergers and divestments right 00:13:09.360 --> 00:13:11.659 up to the present day, just constantly reshaping 00:13:11.659 --> 00:13:13.480 its core structure. Their appetite for strategic 00:13:13.480 --> 00:13:15.740 multi -billion dollar growth seems relentless. 00:13:16.019 --> 00:13:19.000 It is. In 2021, they acquired Hill Rum, a major 00:13:19.000 --> 00:13:21.840 player in medical technology, for $12 .5 billion. 00:13:22.799 --> 00:13:24.559 But they're also pruning the portfolio to pay 00:13:24.559 --> 00:13:26.840 down debt and focus on core strengths. Like the 00:13:26.840 --> 00:13:29.980 recent sales. Exactly. In 2023, they sold off 00:13:29.980 --> 00:13:32.580 their biopharma solutions business for $4 .25 00:13:32.580 --> 00:13:36.740 billion. And just recently, in August 2024, they 00:13:36.740 --> 00:13:39.460 agreed to divest their kidney care unit, Vantiv, 00:13:39.480 --> 00:13:42.919 to Carlyle Group for $3 .8 billion. So we have 00:13:42.919 --> 00:13:45.299 a company that, since its founding, has been 00:13:45.299 --> 00:13:48.179 involved in continuous innovation, market consolidation 00:13:48.179 --> 00:13:51.620 and a constant rotation of assets, all while 00:13:51.620 --> 00:13:54.220 accumulating this history of international felonies 00:13:54.220 --> 00:13:56.860 and massive fraud scandals. And this constant 00:13:56.860 --> 00:13:59.399 reshaping and relentless pursuit of market share 00:13:59.399 --> 00:14:02.549 is what brings us to the present day. And why 00:14:02.549 --> 00:14:04.990 their hold on vital health care functions like 00:14:04.990 --> 00:14:09.090 those IV fluids is so absolute. To truly appreciate 00:14:09.090 --> 00:14:11.269 why the failure of a single facility in North 00:14:11.269 --> 00:14:14.009 Carolina has national implications, we really 00:14:14.009 --> 00:14:17.669 need to grasp just how enormous Baxter's operational 00:14:17.669 --> 00:14:20.830 scope remains. That's right. In 2023, their global 00:14:20.830 --> 00:14:24.649 net sales total $14 .8 billion. And they operate 00:14:24.649 --> 00:14:27.549 across three primary, highly critical business 00:14:27.549 --> 00:14:30.090 segments that essentially run the modern hospital. 00:14:30.289 --> 00:14:31.809 OK, so let's break down. those three segments. 00:14:31.990 --> 00:14:34.470 They cover a huge range of necessities, which 00:14:34.470 --> 00:14:36.730 just shows their pervasive reach. First, there's 00:14:36.730 --> 00:14:38.769 medical product and therapies. That segment has 00:14:38.769 --> 00:14:40.929 two core components. One is advanced surgery, 00:14:41.090 --> 00:14:42.990 which develops technologies like specialized 00:14:42.990 --> 00:14:45.409 sealants and hemostatics. Stuff designed to help 00:14:45.409 --> 00:14:47.649 surgeons manage blood loss, improve outcomes. 00:14:48.029 --> 00:14:50.870 Exactly. The other component is infusion therapies 00:14:50.870 --> 00:14:53.169 and technologies, and this is the crucial division 00:14:53.169 --> 00:14:56.490 that produces the intravenous products, the basic 00:14:56.490 --> 00:14:59.429 IV solutions, and the sophisticated tech used 00:14:59.429 --> 00:15:01.740 in drug and fluid delivery. This is the unit 00:15:01.740 --> 00:15:04.539 responsible for that 60 % vulnerability. This 00:15:04.539 --> 00:15:07.080 is the one. Okay, the second major segment is 00:15:07.080 --> 00:15:09.980 healthcare systems and technologies. This sounds 00:15:09.980 --> 00:15:12.179 like the digital and physical infrastructure 00:15:12.179 --> 00:15:15.059 backbone of the hospital moving beyond just the 00:15:15.059 --> 00:15:17.940 consumables. It absolutely is. This segment is 00:15:17.940 --> 00:15:20.419 divided into smaller divisions. Frontline care. 00:15:21.000 --> 00:15:23.919 digital platform and innovations, care and connectivity 00:15:23.919 --> 00:15:27.279 solutions, and global services. So these are 00:15:27.279 --> 00:15:29.779 the products that keep the hospital running intelligently 00:15:29.779 --> 00:15:32.679 patient monitoring, digital integration. Right. 00:15:32.740 --> 00:15:34.460 Digital integration of records and equipment, 00:15:34.759 --> 00:15:37.200 advanced connectivity solutions to ensure seamless 00:15:37.200 --> 00:15:39.639 care. They're essentially selling the infrastructure 00:15:39.639 --> 00:15:41.879 for patient management. And the third segment, 00:15:42.039 --> 00:15:44.580 pharmaceuticals, that focuses on specialty drugs 00:15:44.580 --> 00:15:47.320 designed specifically for acute care in critical 00:15:47.320 --> 00:15:50.299 environments. Correct. This segment includes... 00:15:50.519 --> 00:15:53.080 inhalational anesthetics drugs essential for 00:15:53.080 --> 00:15:55.500 modern surgery and other differentiated hospital 00:15:55.500 --> 00:15:59.059 pharmaceuticals focused on critical areas like 00:15:59.059 --> 00:16:01.580 pain management, critical care support, anti 00:16:01.580 --> 00:16:05.500 -infection treatments, and oncology. This is 00:16:05.500 --> 00:16:08.220 high -stakes medicine. Which makes quality control 00:16:08.220 --> 00:16:11.440 absolutely non -negotiable. You would think so. 00:16:11.799 --> 00:16:13.960 Looking at their global footprint, even a decade 00:16:13.960 --> 00:16:17.379 ago, around 2013, their sales were heavily concentrated. 00:16:17.860 --> 00:16:21.279 42 % were in the United States and 30 % in Europe. 00:16:21.610 --> 00:16:24.070 That's nearly three quarters of their sales concentrated 00:16:24.070 --> 00:16:27.850 in just two major regulated markets. It underscores 00:16:27.850 --> 00:16:29.870 their market dominance in high value, sophisticated 00:16:29.870 --> 00:16:32.370 health care systems. And their investment in 00:16:32.370 --> 00:16:35.029 the future in R &D has historically been substantial, 00:16:35.230 --> 00:16:38.269 too. It has. In 2013, Baxter reported spending 00:16:38.269 --> 00:16:41.610 more than $1 .2 billion on research and development. 00:16:41.909 --> 00:16:44.309 It shows they were committed to maintaining their 00:16:44.309 --> 00:16:47.039 edge through innovation. In terms of human capital, 00:16:47.139 --> 00:16:49.480 though, their employee count has shifted dramatically 00:16:49.480 --> 00:16:51.419 over the last decade. Yeah, that's primarily 00:16:51.419 --> 00:16:54.399 due to divestitures like the Bex Alta spinoff. 00:16:54.419 --> 00:16:58.179 In 2011, they had approximately 61 ,500 employees 00:16:58.179 --> 00:17:01.620 globally. And now? As of 2024, that number has 00:17:01.620 --> 00:17:04.579 contracted significantly to around 38 ,000. So 00:17:04.579 --> 00:17:07.000 it's a tighter, more focused organization, but 00:17:07.000 --> 00:17:09.660 one still built on a foundation of constant M 00:17:09.660 --> 00:17:12.539 &A. So this massive corporation, driven by the 00:17:12.539 --> 00:17:14.740 relentless pursuit of efficiency and profit, 00:17:14.859 --> 00:17:18.160 like any S &P 500 company also has to manage 00:17:18.160 --> 00:17:20.640 its corporate image. And its responsibility. 00:17:21.079 --> 00:17:23.380 Which brings us to a concept they were early 00:17:23.380 --> 00:17:26.500 adopters of, which provides a fascinating contrast 00:17:26.500 --> 00:17:29.819 to their legal history. The green and greedy 00:17:29.819 --> 00:17:33.000 concept. That phrase, green and greedy, is provocative. 00:17:33.359 --> 00:17:36.000 It argues that environmental stewardship doesn't 00:17:36.000 --> 00:17:38.359 have to be a drag on profit. It can actually 00:17:38.359 --> 00:17:41.000 generate savings. It was a movement that gained 00:17:41.000 --> 00:17:43.920 traction in the late 1990s and Baxter embraced 00:17:43.920 --> 00:17:46.160 it early. They essentially made the argument 00:17:46.160 --> 00:17:48.859 that waste in the manufacturing process is, by 00:17:48.859 --> 00:17:51.630 definition, inefficiency. So if you reduce waste, 00:17:51.869 --> 00:17:54.390 reduce emissions, conserve energy, you are simultaneously 00:17:54.390 --> 00:17:56.869 helping the planet and cutting your costs. And 00:17:56.869 --> 00:17:59.630 we have a specific report from 1997 that confirms 00:17:59.630 --> 00:18:01.589 this operational philosophy worked for them. 00:18:01.710 --> 00:18:04.529 We do. The internal analysis showed that the 00:18:04.529 --> 00:18:07.369 changes they implemented to reduce environmental 00:18:07.369 --> 00:18:10.519 impacts like cutting hazardous waste streams, 00:18:10.799 --> 00:18:13.839 lowering air emissions, and optimizing energy 00:18:13.839 --> 00:18:16.859 use generated savings that actually exceeded 00:18:16.859 --> 00:18:19.500 their costs. They produced a quantifiable net 00:18:19.500 --> 00:18:21.700 profit from being environmentally conscious. 00:18:22.119 --> 00:18:24.619 And this wasn't just a one -off PR stunt. They 00:18:24.619 --> 00:18:27.660 established continuous goals. For example, in 00:18:27.660 --> 00:18:29.839 2009, they announced they had reached several 00:18:29.839 --> 00:18:32.359 environmentally friendly goals and were setting 00:18:32.359 --> 00:18:35.180 new aggressive ones. It's a compelling example 00:18:35.180 --> 00:18:38.400 of how a major global manufacturer can align 00:18:38.509 --> 00:18:41.450 ecological goals with financial efficiency. But 00:18:41.450 --> 00:18:44.250 this efficiency obsession, while good for the 00:18:44.250 --> 00:18:46.569 planet and the bottom line, can become a double 00:18:46.569 --> 00:18:49.309 -edged sword, can't it? Absolutely. That same 00:18:49.309 --> 00:18:51.650 drive to reduce costs and maximize efficiency, 00:18:51.930 --> 00:18:54.410 which works so well for reducing energy waste, 00:18:54.589 --> 00:18:57.069 can lead to dangerous shortcuts when it's applied 00:18:57.069 --> 00:18:59.410 to high -stakes supply chain sourcing, as we're 00:18:59.410 --> 00:19:01.549 about to see. It's the paradox of the modern 00:19:01.549 --> 00:19:04.799 giant. It is highly responsible and efficient 00:19:04.799 --> 00:19:06.779 in its internal operations and environmental 00:19:06.779 --> 00:19:09.880 goals, while at the same time willing to compromise 00:19:09.880 --> 00:19:13.119 on external sourcing and quality control if it 00:19:13.119 --> 00:19:15.299 provides a financial advantage. And to provide 00:19:15.299 --> 00:19:18.240 a necessary counterbalance, Baxter also dedicates 00:19:18.240 --> 00:19:21.039 resources to traditional corporate social responsibility 00:19:21.039 --> 00:19:24.039 and philanthropy, which helps soften that highly 00:19:24.039 --> 00:19:26.880 focused corporate image. They absolutely do. 00:19:27.019 --> 00:19:29.920 We see programs like Science at Work. Launched 00:19:29.920 --> 00:19:32.619 in 2008, which specifically supports teacher 00:19:32.619 --> 00:19:34.599 training and student development in health care 00:19:34.599 --> 00:19:37.220 and biotech fields within Chicago public schools. 00:19:37.420 --> 00:19:39.700 So a direct investment in the future workforce. 00:19:40.099 --> 00:19:42.539 Right. They also have a strong track record of 00:19:42.539 --> 00:19:45.119 being recognized for community involvement. They 00:19:45.119 --> 00:19:48.160 were included in the Civic 50 list in 2013 and 00:19:48.160 --> 00:19:50.339 featured in Corporate Responsibility Magazine's 00:19:50.339 --> 00:19:53.200 100 Best Corporate Citizens list in 2014. And 00:19:53.200 --> 00:19:55.299 that was their 13th year on that list. It was 00:19:55.299 --> 00:19:57.740 a sustained commitment. And their employee involvement 00:19:57.740 --> 00:20:00.420 is noteworthy, too. In 2014, something like 6 00:20:00.420 --> 00:20:03.299 ,300 employees volunteered their time through 00:20:03.299 --> 00:20:05.619 their Dollars for Doers program, focusing on 00:20:05.619 --> 00:20:07.480 health care, the environment, and education. 00:20:07.819 --> 00:20:10.279 So we're looking at a corporate entity that is 00:20:10.279 --> 00:20:13.099 innovative, highly responsible in its internal 00:20:13.099 --> 00:20:16.200 efficiencies, and charitable giving on one hand. 00:20:16.380 --> 00:20:19.539 And consistently compromised by massive, often 00:20:19.539 --> 00:20:22.240 fatal, quality and legal breaches on the other. 00:20:22.539 --> 00:20:26.079 And it's that second, darker identity that puts 00:20:26.079 --> 00:20:28.960 the current 5E shortage into its darkest context. 00:20:29.279 --> 00:20:31.140 Okay, this section is really the core of our 00:20:31.140 --> 00:20:34.299 deep dive. The history of Baxter's product defects 00:20:34.299 --> 00:20:37.200 and contamination is not a string of bad luck. 00:20:37.400 --> 00:20:40.180 It is a decades -long pattern of systemic failures 00:20:40.180 --> 00:20:42.859 that reveal a fundamental and sometimes fatal 00:20:42.859 --> 00:20:46.059 issue with prioritizing cost or supply over public 00:20:46.059 --> 00:20:47.960 safety. And we have to start with the legacy 00:20:47.960 --> 00:20:50.220 of unsafe blood products. which is one of the 00:20:50.220 --> 00:20:52.700 most tragic and ethically damning chapters in 00:20:52.700 --> 00:20:54.819 the history of global medicine. Right. Back in 00:20:54.819 --> 00:20:58.259 1975, Baxter, then operating as Travenol, had 00:20:58.259 --> 00:21:00.200 to withdraw a clotting factor product called 00:21:00.200 --> 00:21:02.380 hemophil. After it was associated with an outbreak 00:21:02.380 --> 00:21:05.039 of hepatitis B, this was an early serious warning 00:21:05.039 --> 00:21:07.119 sign about the dangers of contaminated blood 00:21:07.119 --> 00:21:09.619 products. But the most egregious failure involves 00:21:09.619 --> 00:21:12.779 HIV contamination in the 1980s, and the source 00:21:12.779 --> 00:21:15.690 material reveals a crucial detail. Baxter continued 00:21:15.690 --> 00:21:18.690 to use U .S. prism plasma in their factor concentrate 00:21:18.690 --> 00:21:23.230 production until October 1983. That date is the 00:21:23.230 --> 00:21:25.910 critical failure point. Prism populations were 00:21:25.910 --> 00:21:28.789 considered extremely high risk for various virus 00:21:28.789 --> 00:21:32.059 transmissions, including HIV and hepatitis. And 00:21:32.059 --> 00:21:34.700 here is the truly damning part. Go on. Baxter 00:21:34.700 --> 00:21:37.480 continued this practice for 11 months after entering 00:21:37.480 --> 00:21:39.779 into a binding agreement with the FDA that they 00:21:39.779 --> 00:21:42.880 would no longer use high -risk U .S. prison plasma. 00:21:43.160 --> 00:21:45.599 So this wasn't an oversight. No. This was a calculated 00:21:45.599 --> 00:21:48.220 decision to prioritize the continuity of supply 00:21:48.220 --> 00:21:51.680 and cost management over a known specific high 00:21:51.680 --> 00:21:54.680 -risk safety protocol. It's difficult to overstate 00:21:54.680 --> 00:21:57.180 the magnitude of that decision. It shows a deliberate 00:21:57.180 --> 00:21:59.500 disregard for public health standards when confronted 00:21:59.500 --> 00:22:02.180 with the disruption of supply. and the consequences 00:22:02.180 --> 00:22:04.559 were devastating and long -lasting. Leading to 00:22:04.559 --> 00:22:08.359 massive legal settlements years later. In 1996, 00:22:08.759 --> 00:22:10.900 Baxter was one of four companies involved in 00:22:10.900 --> 00:22:14.680 a massive $640 million settlement for hemophiliacs 00:22:14.680 --> 00:22:17.319 in the U .S. who had been infected with HIV through 00:22:17.319 --> 00:22:19.579 contaminated blood clotting concentrates. And 00:22:19.579 --> 00:22:21.859 the tragedy was global. In Japan, they agreed 00:22:21.859 --> 00:22:24.980 to settle a lawsuit involving 200 Japanese hemophilia 00:22:24.980 --> 00:22:26.940 patients infected with unheated contaminated 00:22:26.940 --> 00:22:29.839 products. With each victim receiving over $411 00:22:29.839 --> 00:22:33.130 ,000. The history of their blood products is 00:22:33.130 --> 00:22:35.549 just fraught with failures in sourcing, handling, 00:22:35.710 --> 00:22:37.849 and a deliberate failure to adhere to safety 00:22:37.849 --> 00:22:40.329 agreements. That specific timeline operating 00:22:40.329 --> 00:22:43.029 for almost a year in direct contravention of 00:22:43.029 --> 00:22:45.250 an FDA agreement is a theme we need to carry 00:22:45.250 --> 00:22:47.750 forward. When profit or supply is threatened, 00:22:48.049 --> 00:22:50.710 quality control systems seem to break down at 00:22:50.710 --> 00:22:53.740 Baxter. Exactly. Fast forward nearly two decades 00:22:53.740 --> 00:22:56.119 to 2001 and we encounter the Althane disaster. 00:22:56.460 --> 00:22:58.720 This was a series of sudden unexplained deaths 00:22:58.720 --> 00:23:01.299 across multiple continents linked to their life 00:23:01.299 --> 00:23:03.579 -sustaining dialysis equipment. Over 50 kidney 00:23:03.579 --> 00:23:05.759 failure patients died suddenly in countries including 00:23:05.759 --> 00:23:09.359 Spain, Croatia, Italy, Germany, Taiwan, Colombia, 00:23:09.440 --> 00:23:12.099 and the USA. Primarily in Nebraska and Texas. 00:23:12.519 --> 00:23:15.220 And hemodialysis is a blood filtering process. 00:23:15.599 --> 00:23:17.700 The patient's blood is cycled through the Althane 00:23:17.700 --> 00:23:20.470 equipment to remove toxins. So when a patient 00:23:20.470 --> 00:23:22.329 dies suddenly during this process, the failure 00:23:22.329 --> 00:23:24.890 is acute and catastrophic. Right. And the common 00:23:24.890 --> 00:23:26.710 denominator was that all these patients had received 00:23:26.710 --> 00:23:29.690 treatment using L8 hemodialysis equipment manufactured 00:23:29.690 --> 00:23:32.190 by Baxter International. Given the scope deaths 00:23:32.190 --> 00:23:34.829 across multiple countries over a short period, 00:23:35.089 --> 00:23:38.009 this strongly suggests a systemic manufacturing 00:23:38.009 --> 00:23:41.730 failure in the device itself. It does. Perhaps 00:23:41.730 --> 00:23:44.069 in the chemical composition of the filter or 00:23:44.069 --> 00:23:46.930 a widespread sterilization issue. It confirms 00:23:46.930 --> 00:23:49.529 that quality control failures were endemic across 00:23:49.529 --> 00:23:52.230 multiple vital product lines. But if you want 00:23:52.230 --> 00:23:54.589 the perfect case study, in the danger of the 00:23:54.589 --> 00:23:57.509 global fragmented and cost -optimized medical 00:23:57.509 --> 00:24:00.230 supply chain and the source of the type of risk 00:24:00.230 --> 00:24:02.829 that leads to our current IV shortage, you have 00:24:02.829 --> 00:24:05.410 to look at the 2008 heparin adulteration scandal. 00:24:05.630 --> 00:24:08.230 This is a masterclass in how cutting costs can 00:24:08.230 --> 00:24:10.730 become fatal. This incident was catastrophic 00:24:10.730 --> 00:24:13.609 in terms of public health outcomes. It was linked 00:24:13.609 --> 00:24:18.490 to 81 documented deaths and 785 severe allergic 00:24:18.490 --> 00:24:21.619 reactions in the United States alone. Baxter's 00:24:21.619 --> 00:24:23.940 blood thinning products were contaminated. It 00:24:23.940 --> 00:24:27.039 forced an immediate voluntary recall and a full 00:24:27.039 --> 00:24:29.140 investigation. And the investigation quickly 00:24:29.140 --> 00:24:31.500 revealed that one of the raw ingredients used 00:24:31.500 --> 00:24:33.799 to manufacture the heparin was contaminated, 00:24:33.819 --> 00:24:37.470 not just with a stray molecule, but... Ranging 00:24:37.470 --> 00:24:39.930 from 5 to 20 percent of the material being a 00:24:39.930 --> 00:24:42.470 completely foreign substance. So the focus of 00:24:42.470 --> 00:24:44.990 the investigation turned immediately to the source 00:24:44.990 --> 00:24:48.289 of the raw material, a China -based subcontractor 00:24:48.289 --> 00:24:50.710 named Changzi Scientific Protein Laboratories. 00:24:50.910 --> 00:24:52.950 And this is where the regulatory details become 00:24:52.950 --> 00:24:56.170 paramount for you, the listener. How did intentional 00:24:56.170 --> 00:24:58.190 counterfeiting reach such a critical medical 00:24:58.190 --> 00:25:00.890 product? It's because this specific Chinese facility 00:25:00.890 --> 00:25:03.710 was never subjected to inspection by U .S. FDA 00:25:03.710 --> 00:25:06.549 officials. Never. Why? Because the company was 00:25:06.549 --> 00:25:08.869 registered purely as a chemical company, not 00:25:08.869 --> 00:25:11.210 a pharmaceutical manufacturer. That's a staggering 00:25:11.210 --> 00:25:13.529 loophole. It is. Because of that registration 00:25:13.529 --> 00:25:16.750 status, it also avoided certification by Chinese 00:25:16.750 --> 00:25:19.869 FDA officials for use in pharmaceutical products. 00:25:20.049 --> 00:25:22.190 So they were operating completely off the regulatory 00:25:22.190 --> 00:25:24.549 radar of both the country where the drug was 00:25:24.549 --> 00:25:26.769 used and the country where the ingredient was 00:25:26.769 --> 00:25:29.130 sourced. Which allowed the contamination to occur 00:25:29.130 --> 00:25:32.289 without any official oversight. And the contaminant 00:25:32.289 --> 00:25:35.430 itself was insidious. It was identified as an 00:25:35.430 --> 00:25:38.710 oversulfated derivative of chondroitin sulfate. 00:25:39.289 --> 00:25:41.569 Now, chondroitin sulfate is a naturally occurring 00:25:41.569 --> 00:25:44.150 substance, often used in supplements. Right. 00:25:44.289 --> 00:25:46.829 But the oversulfated derivative is not naturally 00:25:46.829 --> 00:25:49.230 occurring. It has to be manufactured intentionally. 00:25:49.309 --> 00:25:52.089 This is key, and it connects directly back to 00:25:52.089 --> 00:25:54.529 that cost -cutting mentality we discussed. The 00:25:54.529 --> 00:25:56.170 counterfeit was almost certainly intentional. 00:25:56.490 --> 00:25:59.470 It cost only a fraction of the true heparin precursor 00:25:59.470 --> 00:26:01.450 chemical. And crucially, it was scientifically 00:26:01.450 --> 00:26:04.369 engineered to bypass existing quality control 00:26:04.369 --> 00:26:07.390 tests because it mimicked the in vitro properties 00:26:07.390 --> 00:26:10.690 of... real heparin. It was designed to deceive 00:26:10.690 --> 00:26:13.230 the pharmaceutical company purchasing it. The 00:26:13.230 --> 00:26:15.650 raw heparin batches were found to have been cut 00:26:15.650 --> 00:26:18.230 with this counterfeit substance at shocking percentages, 00:26:18.509 --> 00:26:21.130 starting around 2 % and going all the way up 00:26:21.130 --> 00:26:24.430 to 60 % contamination in some samples. The motivation 00:26:24.430 --> 00:26:27.529 was attributed both to cost effectiveness and 00:26:27.529 --> 00:26:30.150 a shortage of suitable pigs, which are the source 00:26:30.150 --> 00:26:33.109 of true heparin precursor chemical in mainland 00:26:33.109 --> 00:26:36.359 China at the time. The conclusion is just unavoidable. 00:26:36.500 --> 00:26:39.420 This was intentional, large scale counterfeiting 00:26:39.420 --> 00:26:42.180 driven by greed that resulted in dozens of American 00:26:42.180 --> 00:26:45.680 deaths and exposed a profound systemic failure 00:26:45.680 --> 00:26:48.759 of Baxter's sourcing due diligence. They relied 00:26:48.759 --> 00:26:50.940 on the cheapest, least regulated part of the 00:26:50.940 --> 00:26:53.200 supply chain for a product that literally saves 00:26:53.200 --> 00:26:56.180 lives every single day. And if that wasn't enough 00:26:56.180 --> 00:26:58.160 to challenge the integrity of their quality control, 00:26:58.400 --> 00:27:01.099 we had the astonishing near miss the following 00:27:01.099 --> 00:27:03.299 year. It's sometimes chillingly described as 00:27:03.299 --> 00:27:05.859 the accidental bioweapon incident. Involving 00:27:05.859 --> 00:27:08.140 avian flu in 2009. That sounds like something 00:27:08.140 --> 00:27:10.220 out of a techno thriller, not a corporate filing. 00:27:10.400 --> 00:27:12.940 Detail this for us, please. So Baxter was supplying 00:27:12.940 --> 00:27:16.460 samples of the seasonal flu virus, H3N2, to a 00:27:16.460 --> 00:27:18.640 series of European research labs for testing 00:27:18.640 --> 00:27:21.119 and vaccine development. Those samples were accidentally 00:27:21.119 --> 00:27:24.640 mixed or contaminated with the deadly live avian 00:27:24.640 --> 00:27:27.599 flu virus, H5N1. That is absolutely frightening. 00:27:28.059 --> 00:27:30.579 H5N1 has an extremely high mortality rate in 00:27:30.579 --> 00:27:33.279 humans. A potentially catastrophic public health 00:27:33.279 --> 00:27:36.160 disaster was only averted by, what, pure chance? 00:27:36.480 --> 00:27:38.279 A failed test in a completely different country, 00:27:38.339 --> 00:27:41.200 yes. The contamination was only caught after 00:27:41.200 --> 00:27:43.779 a vaccine made from the contaminated H3N2 material 00:27:43.779 --> 00:27:46.859 was tested on animals in a lab in the Czech Republic, 00:27:46.980 --> 00:27:49.839 and those test animals died. If that test hadn't 00:27:49.839 --> 00:27:51.880 been performed, or if the sample had been moved 00:27:51.880 --> 00:27:54.279 directly into mass production? The consequences 00:27:54.279 --> 00:27:56.640 are unimaginable. It means a commercial supplier 00:27:57.049 --> 00:28:00.029 accidentally distributed live, deadly avian flu 00:28:00.029 --> 00:28:03.309 virus to multiple high -security European labs. 00:28:03.529 --> 00:28:05.710 And Baxter's public response. They claimed that 00:28:05.710 --> 00:28:07.569 the controls over the distribution of the virus 00:28:07.569 --> 00:28:09.650 were stringent and that there was little chance 00:28:09.650 --> 00:28:12.170 of the lethal virus harming humans. But the fact 00:28:12.170 --> 00:28:14.609 remains that the controls failed spectacularly. 00:28:14.650 --> 00:28:16.970 It speaks volumes about their internal safety 00:28:16.970 --> 00:28:19.490 and quality assurance systems. Especially in 00:28:19.490 --> 00:28:22.230 their biological products division. And finally, 00:28:22.250 --> 00:28:24.529 we should briefly touch on other major device 00:28:24.529 --> 00:28:27.329 failures and legal costs. that underscore this 00:28:27.329 --> 00:28:30.049 pattern of trouble. Right. In 2010, the FDA ordered 00:28:30.049 --> 00:28:33.269 the recall of all of Baxter's colleague infusion 00:28:33.269 --> 00:28:35.890 pumps from the market. Because they were associated 00:28:35.890 --> 00:28:39.210 with a staggering 87 recalls and deaths over 00:28:39.210 --> 00:28:42.630 time. Infusion pumps are, again, essential for 00:28:42.630 --> 00:28:45.329 accurate drug delivery. A continuous series of 00:28:45.329 --> 00:28:47.849 failures led to the FDA forcing a market removal 00:28:47.849 --> 00:28:50.470 order. That's a serious regulatory intervention. 00:28:51.920 --> 00:28:54.380 Also in 2010, there was the Propofol case in 00:28:54.380 --> 00:28:57.680 Las Vegas. A jury ordered Baxter as the distributor 00:28:57.680 --> 00:29:00.180 and Teva Pharmaceuticals as the manufacturer 00:29:00.180 --> 00:29:03.900 to pay $144 million to patients infected with 00:29:03.900 --> 00:29:06.019 hepatitis C. And we should be clear that the 00:29:06.019 --> 00:29:07.920 patients were infected because medical staff 00:29:07.920 --> 00:29:10.559 wrongly reused dirty medical supplies to administer 00:29:10.559 --> 00:29:13.519 the drug. Right. But despite the Propofol label 00:29:13.519 --> 00:29:15.480 clearly stating it was for single patient use 00:29:15.480 --> 00:29:17.900 only, and despite the requirement for strict 00:29:17.900 --> 00:29:20.779 aseptic procedures, the litigation still resulted 00:29:20.779 --> 00:29:23.220 in a mess. massive payout. Baxter was party to 00:29:23.220 --> 00:29:25.380 the suit, highlighting their liability and role 00:29:25.380 --> 00:29:27.720 in the distribution chain, even if the primary 00:29:27.720 --> 00:29:30.039 negligence was on the medical staff. And we can't 00:29:30.039 --> 00:29:32.140 forget the financial misconduct that echoes the 00:29:32.140 --> 00:29:35.470 Caremark scandal. In 2009. Kentucky's attorney 00:29:35.470 --> 00:29:38.069 general announced a $2 million settlement with 00:29:38.069 --> 00:29:40.710 Baxter for inflating the cost of intravenous 00:29:40.710 --> 00:29:43.190 drugs sold to Kentucky Medicaid. And the inflation 00:29:43.190 --> 00:29:46.910 was shocking, at times as much as 1 ,300 % above 00:29:46.910 --> 00:29:49.349 normal pricing. So we have a clear, continuous 00:29:49.349 --> 00:29:52.250 historical record spanning from the 1970s right 00:29:52.250 --> 00:29:55.349 up to the 2010s that shows consistent, serious 00:29:55.349 --> 00:29:58.740 lapses. Using unapproved plasma long past an 00:29:58.740 --> 00:30:01.859 FDA agreement, major contamination causing widespread 00:30:01.859 --> 00:30:04.579 death and illness, distribution of a deadly virus, 00:30:04.759 --> 00:30:07.079 and significant financial misconduct. It seems 00:30:07.079 --> 00:30:09.339 like innovation and integrity exist in separate 00:30:09.339 --> 00:30:11.759 divisions within this company. And now we loop 00:30:11.759 --> 00:30:14.299 all the way back to where we started. The 2024 00:30:14.299 --> 00:30:17.380 IV fluid shortage caused by a hurricane hitting 00:30:17.380 --> 00:30:19.680 a single facility in Marion, North Carolina. 00:30:19.779 --> 00:30:24.140 That one single external event shut down 60 % 00:30:24.140 --> 00:30:26.119 of the U .S. supply chain for the most basic 00:30:26.119 --> 00:30:28.579 life -sustaining medical necessity. The history 00:30:28.579 --> 00:30:31.619 we just reviewed helps us put that shortage into 00:30:31.619 --> 00:30:34.279 a necessary and frankly chilling perspective. 00:30:34.940 --> 00:30:37.539 We see a core contradiction in Baxter International. 00:30:38.119 --> 00:30:40.519 They are absolutely essential for modern health 00:30:40.519 --> 00:30:43.619 care. They provide the backbone of IVs, dialysis 00:30:43.619 --> 00:30:45.599 equipment, surgical products, critical drugs. 00:30:45.759 --> 00:30:47.980 They are the definition of critical infrastructure. 00:30:48.339 --> 00:30:50.759 Yet their history is peppered with critical safety 00:30:50.759 --> 00:30:54.119 lapses, legal compromises, and sourcing failures. 00:30:54.400 --> 00:30:58.140 The Arab League boycott felony, the multi -million 00:30:58.140 --> 00:31:01.240 dollar Caremark kickback scheme using prison 00:31:01.240 --> 00:31:04.359 plasma long past their FDA agreement, the Althane 00:31:04.359 --> 00:31:07.400 disaster, and the fatal intentional heparin. 00:31:07.440 --> 00:31:09.559 counterfeiting scandal. The current IV fluid 00:31:09.559 --> 00:31:12.160 shortage isn't just a weather story. And it's 00:31:12.160 --> 00:31:14.619 not a simple logistical issue. It is the latest 00:31:14.619 --> 00:31:16.720 data point in a long history of supply chain 00:31:16.720 --> 00:31:18.579 vulnerability. Whether that vulnerability is 00:31:18.579 --> 00:31:20.740 caused by corporate malfeasance. Like the 11 00:31:20.740 --> 00:31:23.000 -month use of high -risk plasma. Intentional 00:31:23.000 --> 00:31:25.039 criminal sourcing overseas. Heparin contamination. 00:31:25.460 --> 00:31:27.880 Or simply geographical concentration. Hurricane 00:31:27.880 --> 00:31:30.519 Aline. So what does this all mean for you, the 00:31:30.519 --> 00:31:33.420 listener, and for the broader public health system 00:31:33.420 --> 00:31:36.940 that you depend on? This is a crucial high stakes 00:31:36.940 --> 00:31:40.519 lesson in the dangers of relying on highly concentrated 00:31:40.519 --> 00:31:43.579 manufacturing for essential medical supplies. 00:31:43.839 --> 00:31:47.420 We have identified multiple systemic risks hidden 00:31:47.420 --> 00:31:50.200 within this one Fortune 500 company's history. 00:31:50.359 --> 00:31:52.650 You have the sourcing risk, right? demonstrated 00:31:52.650 --> 00:31:55.230 by the HIV contamination and the heparin scandal, 00:31:55.529 --> 00:31:58.549 where cost -cutting led to catastrophic and sometimes 00:31:58.549 --> 00:32:01.609 fatal reliance on non -certified, criminally 00:32:01.609 --> 00:32:04.470 compromised foreign suppliers. You have the ethical 00:32:04.470 --> 00:32:06.829 and regulatory risk demonstrated by the felony 00:32:06.829 --> 00:32:09.589 conviction for violating anti -boycott laws and 00:32:09.589 --> 00:32:11.789 the massive kickback schemes that show a foundational 00:32:11.789 --> 00:32:14.250 disregard for compliance when profit is on the 00:32:14.250 --> 00:32:15.920 table. And finally, you have the geographical 00:32:15.920 --> 00:32:17.940 concentration risk, which is what manifested 00:32:17.940 --> 00:32:21.500 in 2024. When 60 % of a life -saving day -to 00:32:21.500 --> 00:32:24.319 -day product comes from one location, the entire 00:32:24.319 --> 00:32:26.759 healthcare system is exposed to any single point 00:32:26.759 --> 00:32:29.759 of failure. Be it a flood, a fire, or a quality 00:32:29.759 --> 00:32:32.119 control lapse. We have to move beyond simply 00:32:32.119 --> 00:32:34.480 reacting to the next crisis. The challenge is 00:32:34.480 --> 00:32:37.559 structural. It is. It forces us to acknowledge 00:32:37.559 --> 00:32:40.059 that while complexity ends the supply chain like 00:32:40.059 --> 00:32:42.579 using unregistered chemical companies in China 00:32:42.579 --> 00:32:45.039 for pharmaceutical ingredients, creates enormous 00:32:45.039 --> 00:32:47.539 cost savings and efficiency, it fundamentally 00:32:47.539 --> 00:32:50.859 introduces unknowable, opaque risks that can 00:32:50.859 --> 00:32:53.640 result in mass fatalities. The system failed 00:32:53.640 --> 00:32:56.380 to build redundancy because redundancy is inefficient. 00:32:57.000 --> 00:32:59.279 It's a fundamental reminder that efficiency at 00:32:59.279 --> 00:33:01.599 the expense of redundancy is incredibly dangerous 00:33:01.599 --> 00:33:03.859 when you're dealing with critical public health 00:33:03.859 --> 00:33:06.299 infrastructure. We have to view resilience as 00:33:06.299 --> 00:33:08.900 an essential cost, not a burdensome expense. 00:33:09.140 --> 00:33:11.319 Absolutely. And that leaves us with this final 00:33:11.319 --> 00:33:13.799 provocative thought for you to continue mulling 00:33:13.799 --> 00:33:16.480 over. Given that the U .S. relies on one single 00:33:16.480 --> 00:33:19.279 facility. For 60 % of its critical IV fluids, 00:33:19.519 --> 00:33:22.500 what are the broader unseen risks hiding in the 00:33:22.500 --> 00:33:25.160 concentrated supply chains for other essential, 00:33:25.400 --> 00:33:28.019 life -saving medical products? Products we never 00:33:28.019 --> 00:33:30.140 think about until they're gone, like sterile 00:33:30.140 --> 00:33:32.880 syringes, basic anesthetic gases, or specialized 00:33:32.880 --> 00:33:35.619 surgical tools. And how should global health 00:33:35.619 --> 00:33:37.460 systems fundamentally restructure themselves 00:33:37.460 --> 00:33:40.799 to absorb the shock of the next inevitable failure, 00:33:41.079 --> 00:33:43.559 whether it's an intentional counterfeit, a natural 00:33:43.559 --> 00:33:45.500 disaster, or a regulatory breach?